A review of therapeutic agents for the management of pulmonary arterial hypertension

被引：10

作者：

Hahn, Stella S. ^{[1
]}

Makaryus, Mina ^{[1
]}

Talwar, Arunabh ^{[1
]}

Narasimhan, Mangala ^{[1
]}

Zaidi, Gulrukh ^{[1
]}

机构：

[1] Northwell Hlth, Div Pulm Crit Care & Sleep Med, 410 Lakeville Rd,Suite 107, New Hyde Pk, NY 11042 USA

来源：

THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE | 2017年 / 11卷 / 01期

关键词：

pulmonary arterial hypertension; prostanoid; endothelin receptor antagonist; phosphodiesterase inhibitor; soluble guanylate cyclase stimulator; ENDOTHELIN RECEPTOR ANTAGONIST; RANDOMIZED CONTROLLED-TRIAL; CONTINUOUS INTRAVENOUS EPOPROSTENOL; NITRIC-OXIDE SYNTHASE; 5 INHIBITOR THERAPY; DOUBLE-BLIND; INHALED ILOPROST; ORAL TREPROSTINIL; COMBINATION THERAPY; PROSTACYCLIN ANALOG;

D O I：

10.1177/1753465816665289

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Pulmonary arterial hypertension (PAH) is an uncommon, progressive and life threatening disease characterized by a proliferative vasculopathy of the small muscular pulmonary arterioles resulting in elevated pulmonary vascular resistance and eventually right ventricular failure. An increasing understanding of the pathobiology of PAH and its natural history has led to the development of numerous targeted therapies. Despite these advances there is significant progression of disease and the survival rate remains low. This article reviews the agents currently available for the medical management of PAH.

引用

页码：46 / 63

页数：18

共 50 条

[31] Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
Kim, Hyung Yoon
Kim, Kye Hun
KOREAN CIRCULATION JOURNAL, 2019, 49 (04) : 361 - 362
[32] New Therapeutic Target for Pulmonary Arterial Hypertension
Yoon, Kyung Lim
KOREAN CIRCULATION JOURNAL, 2018, 48 (12) : 1145 - 1147
[33] Pulmonary arterial hypertension: New therapeutic modalities
Pitsiou, G. G.
Argiropoulou-Pataka, P.
PNEUMON, 2005, 18 (02) : 144 - 155
[34] Pulmonary arterial hypertension: current therapeutic strategies
Puri, Aniket
McGoon, Michael D.
Kushwaha, Sudhir S.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (06): : 319 - 329
[35] Novel therapeutic targets in pulmonary arterial hypertension
Morrell, N.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 15 - 15
[36] Therapeutic innovations to cure pulmonary arterial hypertension
Humbert, Marc
PRESSE MEDICALE, 2011, 40 : 1 - 2
[37] Pulmonary arterial hypertension: current therapeutic strategies
Aniket Puri
Michael D McGoon
Sudhir S Kushwaha
Nature Clinical Practice Cardiovascular Medicine, 2007, 4 : 319 - 329
[38] A review of the management of pulmonary arterial hypertension associated with congenital heart disease
Harries, Carl
Armstrong, Iain
EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2012, 11 (02) : 239 - 247
[39] Current management of pulmonary arterial hypertension
Yerly, Patrick
Prella, Maura
Aubert, John-David
SWISS MEDICAL WEEKLY, 2016, 146 : w14305
[40] The Management of Acute Pulmonary Arterial Hypertension
Hui-li, Gan
CARDIOVASCULAR THERAPEUTICS, 2011, 29 (03) : 153 - 175

← 1 2 3 4 5 →